
Janus Henderson Global Life Sciences Fund
JAGLX
Updated: 22/09/2026, 21:25:59
The Janus Henderson Global Life Sciences Fund primarily focuses its investment strategy on companies operating within the life sciences field. Typically, at least 80% of its net assets (which includes any borrowed funds for investment) are allocated to firms that the portfolio manager believes exhibit a life sciences orientation. Additionally, as a fundamental investment principle, the fund generally commits a minimum of 25% of its total assets to businesses officially classified within the "life sciences" sector.
No summaries found.
- Share price
- $87.93
- Market cap
- $5.87B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 31/12/1998
- Beta
- 0.66
- Last dividend
- $0.00
- Day range
- $87.93 – $87.93
- 52-week range
- $68.31 – $93.51
- 1-day performance
- 0.43%
- 1-year performance
- 28.72%
- Current drawdown (1Y)
- -5.97%
- CIK
- 0000277751
- CUSIP
- 471023671
- ISIN
- US4710236716
- Created
- 07/12/2025, 04:49:29
- Last update
- 22/09/2026, 21:25:59
Track Janus Henderson Global Life Sciences Fund with an AI analyst
See which prediction-market events move JAGLX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.